BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 32679487)

  • 1. Comparison of long-term efficacy, tolerability, and safety of oxcarbazepine, lamotrigine, and levetiracetam in patients with newly diagnosed focal epilepsy: An observational study in the real world.
    Li R; Zhou Q; Ou S; Wang Y; Li Y; Xia L; Pan S
    Epilepsy Res; 2020 Oct; 166():106408. PubMed ID: 32679487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of oxcarbazepine, levetiracetam, and lamotrigine on semen quality, sexual function, and sex hormones in male adults with epilepsy.
    Wu D; Chen L; Ji F; Si Y; Sun H
    Epilepsia; 2018 Jul; 59(7):1344-1350. PubMed ID: 29889310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of levetiracetam and oxcarbazepine monotherapy among Korean patients with newly diagnosed focal epilepsy: A long-term, randomized, open-label trial.
    Kim JH; Lee SK; Loesch C; Namgoong K; Lee HW; Hong SB;
    Epilepsia; 2017 Apr; 58(4):e70-e74. PubMed ID: 28395124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
    Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
    Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Long-Term Effectiveness of a Monotherapy with Five Antiepileptic Drugs for Focal Epilepsy in Adult Patients: A Prospective Cohort Study.
    Zeng QY; Fan TT; Zhu P; He RQ; Bao YX; Zheng RY; Xu HQ
    PLoS One; 2015; 10(7):e0131566. PubMed ID: 26147937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Lamotrigine and Oxcarbazepine Monotherapy Among Chinese Adult Patients With Newly-Diagnosed Focal-Onset Epilepsy: A Prospective Observational Study.
    Chen Y; Wang Q; Xu Y; Wu D; Xu L; Zhu G; Wu X
    Front Neurol; 2022; 13():855498. PubMed ID: 35756921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy comparison of oxcarbazepine and levetiracetam monotherapy among patients with newly diagnosed focal epilepsy in China: A multicenter, open-label, randomized study.
    Zhu H; Deng X; Feng L; Lian Y; Han X; Guo Z; Gou Y; Du Y; Xie L; Yao D; Liu Y; Wu Q; Lan S; Liu K; Zhan P; Wang X; Dang J; Hou Y; Chen K; Zhu Y; Shi Y; Yu Y; Xiao B; Zhu S; Meng H
    CNS Neurosci Ther; 2022 Jul; 28(7):1072-1080. PubMed ID: 35429132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam versus Oxcarbazepine as monotherapy in newly diagnosed focal epilepsy: A systematic review and meta-analysis.
    Kharel S; Ojha R; Khanal S
    Brain Behav; 2022 Nov; 12(11):e2779. PubMed ID: 36184821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of antiepileptic drug use during pregnancy over a period of 12 years in Spain. Efficacy of the newer antiepileptic drugs lamotrigine, levetiracetam, and oxcarbazepine.
    Martinez Ferri M; Peña Mayor P; Perez López-Fraile I; Escartin Siquier A; Martin Moro M; Forcadas Berdusan M;
    Neurologia (Engl Ed); 2018 Mar; 33(2):78-84. PubMed ID: 27452623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study.
    Rosenow F; Schade-Brittinger C; Burchardi N; Bauer S; Klein KM; Weber Y; Lerche H; Evers S; Kovac S; Hallmeyer-Elgner S; Winkler G; Springub J; Niedhammer M; Roth E; Eisensehr I; Berrouschot J; Arnold S; Schröder M; Beige A; Oertel WH; Strzelczyk A; Haag A; Reif PS; Hamer HM;
    J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1093-8. PubMed ID: 22595362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Effectiveness of Antiepileptic Drug Monotherapy in Partial Epileptic Patients: A 7-year Study in an Epilepsy Center in China.
    Zhu F; Lang SY; Wang XQ; Shi XB; Ma YF; Zhang X; Chen YN; Zhang JT
    Chin Med J (Engl); 2015 Nov; 128(22):3015-22. PubMed ID: 26608980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential antiseizure medication sensitivity of the Affective Reactivity Index: A randomized controlled trial in new-onset pediatric focal epilepsy.
    Loring DW; Meador KJ; Shinnar S; Gaillard WD; Wheless JW; Kessler SK; Conry JA; Berl MM; Burns TG; Glauser TA; Kinkead B; Cnaan A
    Epilepsy Behav; 2020 Jan; 102():106687. PubMed ID: 31816478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.
    Marson AG; Appleton R; Baker GA; Chadwick DW; Doughty J; Eaton B; Gamble C; Jacoby A; Shackley P; Smith DF; Tudur-Smith C; Vanoli A; Williamson PR
    Health Technol Assess; 2007 Oct; 11(37):iii-iv, ix-x, 1-134. PubMed ID: 17903391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness at 24 Months of Single-Source Generic Carbamazepine, Lamotrigine, or Levetiracetam in Newly Diagnosed Focal Epilepsy.
    Gurbani S; Chayasirisobhon S; Gurbani A; Tovar S; Pietzsch E; Spurgeon B
    Perm J; 2020 Dec; 25():1-3. PubMed ID: 33635777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures.
    Lerche H; Daniluk J; Lotay N; DeRossett S; Edwards S; Brandt C
    Seizure; 2015 Aug; 30():93-100. PubMed ID: 26216692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy.
    Werhahn KJ; Trinka E; Dobesberger J; Unterberger I; Baum P; Deckert-Schmitz M; Kniess T; Schmitz B; Bernedo V; Ruckes C; Ehrlich A; Krämer G
    Epilepsia; 2015 Mar; 56(3):450-9. PubMed ID: 25684224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of levetiracetam and oxcarbazepine on 4-year fragility fracture risk among prepubertal and pubertal children with epilepsy.
    Whitney DG; Caird MS; Hurvitz EA; Rajapakse CS; Fedak Romanowski EM
    Epilepsia; 2021 Sep; 62(9):2180-2189. PubMed ID: 34250606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative retention rates and long-term tolerability of new antiepileptic drugs.
    Chung S; Wang N; Hank N
    Seizure; 2007 Jun; 16(4):296-304. PubMed ID: 17267243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.
    Weston J; Bromley R; Jackson CF; Adab N; Clayton-Smith J; Greenhalgh J; Hounsome J; McKay AJ; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD010224. PubMed ID: 27819746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population.
    Wang XQ; Lang SY; Shi XB; Tian HJ; Wang RF; Yang F
    Seizure; 2010 Nov; 19(9):562-6. PubMed ID: 20888266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.